The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure-Reference-Cited by-同舟云学术

The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure

Published:1991-11 Issue:3 Volume:79 Page:390-397
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Preisler Harvey D.,Larson Richard A.,Raza Azra,Browman George,Goldberg Jack,Vogler Ralph,Day Roger,Gottlieb Arlan,Vardiman James W.,Bennett John,Kukla Cathi,Grunwald Hans

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1991.tb08046.x/fullpdf

Reference21 articles.

1. Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

2. Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.

3. AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

4. Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro drug sensitivity of leukemic progenitors and P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome;European Journal of Haematology;2009-04-24

2. In vitro sensitivity of hematopoietic progenitors to Tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemia;Cancer Letters;2003-06

3. P15INK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients;Leukemia;2001-10

4. High Remission Rate in Acute Myeloblastic Leukemia with Only Two Days of Chemotherapy;Leukemia & Lymphoma;2001-01

5. Poor prognosis acute myelogenous leukemia 2 — biological and molecular biological characteristics and treatment outcome;Leukemia Research;2000-09